The In Ovo Delivery of CpG Oligonucleotides Protects against Infectious Bronchitis with the Recruitment of Immune Cells into the Respiratory Tract of Chickens

Autor: Upasama De Silva Senapathi, Mohamed Sarjoon Abdul-Cader, Aruna Amarasinghe, Guido van Marle, Markus Czub, Susantha Gomis, Mohamed Faizal Abdul-Careem

Publikováno v: Viruses, Vol 10, Iss 11, p 635 (2018)

The in ovo delivery of cytosine-guanosine (CpG) oligodeoxynucleotides (ODNs) protects chickens against many bacterial and viral infections, by activating the toll-like receptor (TLR)21 signaling pathway. Although the delivery of CpG ODNs in ovo at em

Externí odkaz: https://doaj.org/article/d56722d252594d388c84c51f117c2f82

Comparative innate responses induced by Toll-like receptor (TLR)7 and 21 ligands against infectious bronchitis virus infection

Autor: De Silva Senapathi, Yaseshwari Upasama

Toll-like receptor (TLR)7 and 21 ligands, resiquimod and cytosine-guanosine (CpG) oligonucleotides (ODNs) respectively have been used in ovo (pre-hatch) to enhance or prime an early immune response in chickens to provide protection against microbial

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d5d47011fc7df556ad95f0462d11e559

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

In Ovo Delivered Toll-Like Receptor 7 Ligand, Resiquimod Enhances Host Responses against Infectious Bronchitis Corona Virus (IBV) Infection.

Autor: De Silva Senapathi U; Department of Ecosystem and Public Health, Faculty of Veterinary Medicine, University of Calgary, Health Research Innovation Center 2C53, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada., Aboelkhair M; Virology Department, Faculty of Veterinary Medicine, University of Sadat City, Sadat 999060, Egypt., Puro K; Division of Animal Health, ICAR Research Complex for NEH Region, Umiam, Meghalay 793103, India., Ali M; Department of Ecosystem and Public Health, Faculty of Veterinary Medicine, University of Calgary, Health Research Innovation Center 2C53, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada., Amarasinghe A; Department of Ecosystem and Public Health, Faculty of Veterinary Medicine, University of Calgary, Health Research Innovation Center 2C53, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada., Abdul-Cader MS; Department of Ecosystem and Public Health, Faculty of Veterinary Medicine, University of Calgary, Health Research Innovation Center 2C53, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada., Van Marle G; Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada., Czub M; Department of Ecosystem and Public Health, Faculty of Veterinary Medicine, University of Calgary, Health Research Innovation Center 2C53, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada., Abdul-Careem MF; Department of Ecosystem and Public Health, Faculty of Veterinary Medicine, University of Calgary, Health Research Innovation Center 2C53, 3330 Hospital Drive NW, Calgary, AB T2N 4N1, Canada.

Publikováno v: Vaccines [Vaccines (Basel)] 2020 Apr 15; Vol. 8 (2). Date of Electronic Publication: 2020 Apr 15.